Form 4: Ardelyx CEO Michael Raab Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Ardelyx's CEO, Michael Raab, exercised stock options and sold 35,000 shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- On September 11, 2024, Michael Raab, the President and CEO of Ardelyx, Inc., exercised a stock option to purchase 35,000 shares of Ardelyx common stock at a price of $0.99 per share.
- Simultaneously, Raab sold 35,000 shares of Ardelyx common stock at a weighted average price of $5.6114 per share, with individual sales prices ranging from $5.551 to $5.651.
- These transactions were executed under a 10b5-1 trading plan adopted on December 13, 2023.
- Following these transactions, Raab directly owns 1,220,608 shares of Ardelyx common stock.
- Raab also has indirect ownership of 24,364 shares held in a family trust and 1,000 shares held in trusts for the benefit of his children.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports insider trading activity under a pre-arranged plan. There is no indication of positive or negative implications for the company.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of insider transactions, which are common among publicly traded companies. The use of a 10b5-1 trading plan suggests that the transactions were pre-planned and not based on any material non-public information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| July 25, 2012 | Date of the Michael G. Raab Living Trust. |
| January 6, 2022 | Date from which the stock options vest in monthly installments. |
| December 13, 2023 | Date the Reporting Person adopted the 10b5-1 trading plan. |
| August 2024 | Purchase of 1,099 shares under the Ardelyx Employee Stock Purchase Plan. |
| September 11, 2024 | Date of stock option exercise and share sale. |
| September 13, 2024 | Date of Form 4 filing. |
| January 6, 2032 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.